Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2002 | 1 |
2012 | 1 |
2013 | 1 |
2018 | 1 |
2019 | 1 |
2020 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials.
Lancet HIV. 2024 Feb;11(2):e75-e85. doi: 10.1016/S2352-3018(23)00258-8. Epub 2023 Dec 20.
Lancet HIV. 2024.
PMID: 38141637
Clinical Trial.
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study.
Cahn P, Pozniak AL, Mingrone H, Shuldyakov A, Brites C, Andrade-Villanueva JF, Richmond G, Buendia CB, Fourie J, Ramgopal M, Hagins D, Felizarta F, Madruga J, Reuter T, Newman T, Small CB, Lombaard J, Grinsztejn B, Dorey D, Underwood M, Griffith S, Min S; extended SAILING Study Team.
Cahn P, et al.
Lancet. 2013 Aug 24;382(9893):700-8. doi: 10.1016/S0140-6736(13)61221-0. Epub 2013 Jul 3.
Lancet. 2013.
PMID: 23830355
Clinical Trial.
Item in Clipboard
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial.
Molina JM, Squires K, Sax PE, Cahn P, Lombaard J, DeJesus E, Lai MT, Xu X, Rodgers A, Lupinacci L, Kumar S, Sklar P, Nguyen BY, Hanna GJ, Hwang C; DRIVE-FORWARD Study Group.
Molina JM, et al.
Lancet HIV. 2018 May;5(5):e211-e220. doi: 10.1016/S2352-3018(18)30021-3. Epub 2018 Mar 25.
Lancet HIV. 2018.
PMID: 29592840
Clinical Trial.
Item in Clipboard
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial.
Molina JM, Squires K, Sax PE, Cahn P, Lombaard J, DeJesus E, Lai MT, Rodgers A, Lupinacci L, Kumar S, Sklar P, Hanna GJ, Hwang C, Martin EA; DRIVE-FORWARD trial group.
Molina JM, et al.
Lancet HIV. 2020 Jan;7(1):e16-e26. doi: 10.1016/S2352-3018(19)30336-4. Epub 2019 Nov 15.
Lancet HIV. 2020.
PMID: 31740348
Clinical Trial.
Item in Clipboard
[Ergoferon and oseltamivir in treatment of influenza: results of multicentre randomized comparative clinical trial].
Aver'ianov AV, Babkin AP, Bart BIa, Volchetskiĭ AL, Minina ES, Kozyrev OA, Kostinov MP, Petrov DV, Sel'kova EP, Putilovskiĭ MA, Nechaev VB, Epshteĭn OI, Andrianova EN.
Aver'ianov AV, et al. Among authors: kozyrev oa.
Antibiot Khimioter. 2012;57(7-8):23-30.
Antibiot Khimioter. 2012.
PMID: 23350191
Clinical Trial.
Russian.
Item in Clipboard
[Cardiovascular and metabolic effects in nebulizer therapy of bronchial asthma].
Punin AA, Bogachev RS, Zubkov SK, Kozyrev OA, Khokhlova IuA.
Punin AA, et al. Among authors: kozyrev oa.
Klin Med (Mosk). 2002;80(1):40-3.
Klin Med (Mosk). 2002.
PMID: 11855317
Clinical Trial.
Russian.
Item in Clipboard
Cite
Cite